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Background: Hepatitis B virus infection (HBV) is widespread and it is considered a major health problem
worldwide. The global distribution of HBV varies significantly between countries and between regions of the world.
Among the many factors contributing to the changing epidemiology of viral hepatitis, the movement of people
within and between countries is a potentially important one. In Italy, the number of migrant individuals has been
increasing during the past 25 years. HBV genotype D has been found throughout the world, although its highest
prevalence is in the Mediterranean area, the Middle East and southern Asia. We describe the molecular
epidemiology of HBV in a chronically infected population of migrants (living in Italy), by using the phylogenetic
analysis.
Methods: HBV-DNA was amplified and sequenced from 43 HBV chronically infected patients.
Phylogenetic and evolutionary analysis were performed using both maximum Likelihood and Bayesian methods.
Results and conclusion: Of the 43 HBV S gene isolates from migrants, 25 (58.1 %) were classified as D genotype.
Maximum Likelihood analysis showed an intermixing between Moldavian and foreigners sequences mostly respect
to Italian ones. Italian sequences clustered mostly together in a main clade separately from all others. The
estimation of the time of the tree’s root gave a mean value of 17 years ago, suggesting the origin of the tree back
to 1992 year. The skyline plot showed that the number of infections softly increased until the early 2005s, after
which reached a plateau. Comparing phylogenetic data to the migrants date of arrival in Italy, it should be possible
that migrants arrived in Italy yet infected from their country of origin. In conclusion, this is the first paper where
phylogenetic analysis and genetic evolution has been used to characterize HBV sub genotypes D1 circulation in a
selected and homogenous group of migrants coming from a restricted area of Balkans and to approximately define
the period of infection besides the migration date.
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Hepatitis B virus (HBV) is a circular, partially double-
stranded DNA virus of about 3.7 k bases, of the family
Hepadnaviridae; its genome has four overlapped open
reading frames (ORFs) that codify for: envelope (S/Pre-S),
core (C/pre-C), polymerase (P) and X (HBV-X) proteins
[1, 2]. Infection with HBV affects the liver and results in a
broad spectrum of disease outcomes: the infection can
spontaneously resolve and lead to protective immunity,
result in a chronic infection and cause acute liver failure
[3]. HBV infection is widespread and it is considered a
major health problem worldwide with approximately one
third of the world’s population that has been exposed to
the virus, and an estimated 350 million people are chron-
ically infected [4, 5].
Every year there are over 4 million acute clinical cases of
HBV, and about 25 % of, 1 million people a year, die from
chronic active hepatitis, or primary liver cancer [World
Health Organization. http://www.who.int/csr/disease/
hepatitis/whocdscsrlyo20022/en/index8.html#51].
In Europe the HBV prevalence rates are variables be-
tween different countries: in general, countries in the
south-eastern part are still at high level of endemicity,
while western countries report low prevalence of HBV
infection [3].
Despite the recent decrease in the rate of new cases,
about 7–8,000 new diagnoses are made every year in
Europe [3].
The global distribution of HBV varies significantly
between countries and between regions of the world.
Among the many factors contributing to the changing
epidemiology of viral hepatitis, the movement of
people within and between countries is a potentially
important one [6]. Migration has historically played a
role in influencing demographic changes and public
health.
More than 70 % of the estimated 25 million foreigners
living in the European Union’s countries come from
Eastern and South-Eastern Europe and North Africa.
However, migrants to the European Union (EU) are
diverse in terms of their country of origin, and the number
of immigrants from Latin America, Asia and Sub-Saharan
Africa is growing (http://www.ecdc.europa.eu).
In Italy, the number of migrant individuals has been
increasing during the past 25 years. It has been esti-
mated that, by the end of 2011, 5 million foreign individ-
uals were living in Italy. Of these, 27.4 % were from
European (EU) countries of the EU Community, 23,4 %
from EU countries not belonging to the EU Community,
22.1 % from Africa, 18,8 % from Asia and 8.3 % from
America [7].
Ten genotypes (A-J) that differs genetically by at
least 8 % have so far been identified for HBV [8], some
of which further segregate into sub-genotypes witha mean genetic distance of about 4 % [9]. The
genotypes and sub-genotypes have a distinct ethno-
geographical distribution. Some are ubiquitous, such
as genotype A, which is present in north-western
Europe, North America Central Africa and Asia [10],
and genotype D, which has been found throughout
the world, although its highest prevalence is in the
Mediterranean area, the Middle East and southern
Asia, particularly India [10, 11].
Other genotypes are locally restricted to more limited
geographical areas [8]. The two genotypes responsible
for the majority of infections in Europe are genotype A
(mainly subgenotype A2) in the north-western part of
Europe and genotype D (mainly subgenotypes D1, D2
and D3) in the south eastern Europe and the Mediterranean
area [9].
The aim of the present study was to describe the mo-
lecular epidemiology of HBV in a chronically infected
population of migrants living in Italy, by using the
phylogenetic analysis.
The temporal dynamics was performed by using a
Bayesian approach.
Methods
Patients
Serum samples were from 43 HBV chronically in-
fected patients followed at the Service of International
Medicine of Brescia’s Local Health Authority, in a period
from 2004 to 2010. The Service of International Medicine
(SIM) was created initially in 1990 to provide a free of
charge basic medical assistance for undocumented
migrants.
Patients included in the study were HBsAg positive
with either HBeAg reactivity or HBV-DNA values
greater than 2,000 IU/ml. Upon these criteria they were
defined as having active chronic hepatitis B.
The study was approved by Ethical Committee of
Brescia Health Local Authority and a written informed
consent was obtained from all participating subjects
[12]. All migrants from Moldavia arrived in Italy from
2003 to 2008.
HBV DNA extraction, amplification and sequencing
HBV-DNA was extracted from serum sample at the Na-
tional Institute of Health (Istituto Superiore di Sanita)
and genotyping was performed on HBV-DNA positive
sera. Viral DNA was extracted from 200 μl of serum
using the EZ1 Virus Mini Kit v.2.0 (Qiagen Hilden,
Germany) following the manufacturer’s instructions.
HBV-DNA was amplified by real-time polymerase chain
reaction (PCR) with the Platinum Taq DNA Polymerase
(Invitrogen by Life Technologies Corporation). Single set
of primers corresponding to HBV S gene was used as fol-
low:5′-AGGCGGGGTTTTTCTTGTTGACAA-3′(sense;
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ACCCA-3′(antisense; nt 842–821). The fragment amp-
lified by PCR was 600 base pairs (bp). The PCR condi-
tions were: initial denaturation at 94 °C for 1 min and
30 s, followed by 30 cycles of denaturation at 94 °C for
30 s, annealing at 52° for 30 s, extension at 72 °C for
1 min. A final elongation step of 5 min at 72 °C was in-
cluded at the end of the amplification cycles. Both nega-
tive and positive controls were included in each PCR
run to ensure the absence of contamination and moni-
tor amplification efficiency. The PCR products were
analyzed on 1,2 % agarose gel stained with ethidium
bromide.
The PCR products were purified using the QIAquick
PCR Purification Kit (Qiagen Hilden, Germany) in ac-
cordance with the manufacturer’s instructions. Sequen-
cing reactions were performed using the GenomeLab
DTCS Quick Start KiT (Beckman Coulter, Inc., Fullerton,
CA) and were run on an automated DNA sequencer
(Beckman Coulter, Inc., Fullerton, CA).
A total of 43 sequences were successfully obtained.
The sequences were submitted to GenBank (Accession
Numbers from KR871232 to KR871274).
Sequence dataset
Four different dataset were built. The first one contained
43 HBV S gene sequences from migrants plus 105 geno-
type specific reference sequences downloaded from the
National Centre for Biotechnology Information (NCBI)
(http://www.ncbi.nlm.nih.gov/.); this dataset has been
used to establish the genotype.
The second dataset included 17 Moldovan HBV
sequences previously classified as D1 genotype plus 228
HBV D1 genotype sequences downloaded from NCBI
and it was used to to estimate the S gene mean evolution-
ary rate.
The reference sequences were selected according to
the following inclusion criteria: (i) sequences had already
been published in peer-reviewed journals; (ii) the sub-
type assignment of each sequence was certain; (iii) the
state of origin and the sampling date were known and
clearly established in the original publication.
The third dataset included only the 17 HBV D1 geno-
type Moldovan sequences and was used to perform the
population dynamics and to perform the time scale tree.
The fourth dataset was composed of 418 HBV D1
genotype sequences, 17 of which were the 17 Moldovan
isolates and 401 were D1 genotype foreign sequences
(68 sampled from Italy, 15 from Bulgaria, 35 from
Lebanon, 108 from Iran, 2 from Uzbequistan, 3 from
Tajikistan, 3 from Belarus, 47 from Turkey, 4 from
Poland, 5 from China, 3 from Egypt, 17 from Sudan, 14
from India, 1 from Latvia, 8 from Mongolia, 2 from
Pakistan, 49 from Russia, 11 from Tunisia, 1 from France,4 from Belgium and 1 from Germany) downloaded from
NCBI and selected according to the above inclusion
criteria.
Likelihood mapping
The phylogenetic signal generated by each dataset was
investigated by means of the likelihood mapping analysis
of 10,000 random quartets generated using TreePuzzle
as already described [13]. A likelihood map consists of
an equilateral triangle containing dots representing the
likelihoods of the three possible un-rooted trees for a set
of four sequences (quartets) randomly selected from the
dataset: the dots close to the corners or at the sides rep-
resent, respectively, tree-like (fully resolved phylogenies
in which one tree is clearly better than the others) or
network-like phylogenetic signals (three regions in which
it is not possible to decide between two topologies). The
central area of the map represents a star-like signal, (the
region in which the star tree is optimal). When using
this strategy, if more than 33 % of the dots fall into the
center of the triangle, the data are considered unreliable
for the purposes of phylogenetic inference.
Phylogenetic analysis
The sequences of all dataset were aligned using Clustal
X and manually edited by Bioedit as already described
[14]. The evolutionary model was chosen for each data-
set as the best-fitting nucleotide substitution model in
accordance with the results of the hierarchical likelihood
ratio test (HLRT) implemented in Modeltest software
version 3.7, as already described [14]. The isolate genotype
in the first data set was determinated by using maximum
likelihood (ML) and HKY + I + G as evolutionary model
by Phyml v 3.0 [15].
The evolutionary rate was estimated on the second
data set by HKY + I + G evolutionary model by using
BEAST software 1.7.4 [14].
The evolutionary model for the third data set was
HKY + I + G [14].
The forth dataset to investigate the eventual inter-
mixing between foreign and Moldavian sequences used
GTR + I + G as the best evolutionary model in ML ap-
proach [16].
The statistical robustness and reliability of the branch-
ing order within the phylogenetic trees was confirmed
by the bootstrap analysis, considering as significant stat-
istical support a bootstrap value > 70 % and posterior
probability (pp) in Bayesian analysis (pp > 90 %).
Evolutionary rate estimate and time –scaled phylogeny
reconstruction
To estimate the evolutionary rate on the second data set
both a strict and relaxed clock with an uncorrelated log
normal rate distribution were compared. A Bayesian
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mented in BEAST package 1.7.4 [17, 18] was used. As
coalescent priors, three parametric demographic models
of population growth (constant size, exponential, and
expansion growth) and a Bayesian skyline plot (BSP,
a non-parametric piecewise- constant model) were
compared.
The MCMC chains were run for at least 50 million
generations, and sampled every 5,000 steps. Conver-
gence was assessed on the basis of the effective sam-
pling size (ESS) after a 10 % burn-in [18]. Only ESS
values of > 250 were accepted. Uncertainty in the es-
timates was indicated by 95 % highest posterior
density (95 % HPD) intervals, and the best fitting
models were selected using a Bayes factor (BF, using
marginal likelihoods) implemented in BEAST [18]. In
accordance with Kass and Raftery [19], the strength
of the evidence against H0 (null hypothesis) was
evaluated as follows: 2 ln BF < 0 no evidence; 2–6
weak evidence; 6–10 strong evidence; and > 10 very
strong evidence. A negative 2 ln BF indicates evi-
dence in favor of H0. Only values ≥ 6 were consid-
ered significant.
The time-scaled phylogenetic tree on the third dataset
was reconstructed by using the Bayesian Markov Chain
Monte Carlo approach implementing the evolutionary
model selected by ModelTest, setting the evolutionary
rate to the value previously estimated and the best fitting
models (so as for the clock and the demographic model)
were selected using a Bayes factor (BF, using marginal
likelihoods).
Demographic history
The demographic history was analyzed on the third
dataset on an individual basis by comparing the four co-
alescent models (constant, exponential, expansional, and
BSP) and implementing a relaxed molecular clock model
under the conditions described above.
Results
Likelihood mapping analysis
The phylogenetic noise of each data set was investigated
by means of likelihood mapping. The percentage of dots
falling in the central area of the triangles was 10.6 %,
25.9 %, 27 % and 29 % respectively for the first, second,
third and fourth dataset: as none of the dataset showed
more than 30 % of noise, all of them contained a suffi-
cient phylogenetic signal (Additional file 1: Figure S1,
Panel a, b, c, d).
Phylogenetic analysis
Maximum Likelihood phylogenetic analysis of the first
dataset (Additional file 2: Figure S2) identified different
statistically supported cluster (bootstrap > 70 %).The 43 HBV S gene sequences obtained from migrants
were classified as follow: 25 (58.1 %) genotype D, 1 (2.3 %)
genotype E, 7 (16.3 %) genotype A, 3 (7 %) genotype C, 4
(9.3 %) genotype B and 3 (7 %) sequences were unclassified.
Specifically, of the 7 HBV genotype A isolates, 4
(57.1 %) isolates were classified as subgenotype A2 and 3
(42.9 %) isolates were classified as subgenotype A3.
Amog the 25 genotype D sequences, 6 (24 %) were clas-
sified as subgenotype D2, 1 isolate (4 %) as subgenotype
D3, 18 (72 %) as subgenotype D1 (17 of the 18 D1 sub-
genotype isolates, were from Moldova).
Maximum Likelihood analysis on the the forth data set
showed an intermixing between Moldavian and for-
eigners sequences (Additional file 3: Figure S3).
Most of the Italian sequences clustered together in a
main clade separately from all others.
Evolutionary rate estimate and Bayesian analysis
Implementing strict and relaxed molecular clocks,
MCMC searches were performed, on the second data-
set, and the marginal likelihoods of the obtained trees
were compared using a BF to select the best model and
parameter values. BF analysis showed that the relaxed
clock fitted the data significantly better than the strict
clock (2lnBF between the strict and relaxed clock was
716.556 in favour of the second). Under the relaxed
clock, the BF analysis showed that the Bayesian skyline
plot (BSP) was better than other models (2lnBF > 120).
The estimated mean value of the HBV S gene evolu-
tionary rate for the second dataset was 4.4 × 10−4 (95 %
HPD: 2.6 × 10−4 - 6.2 × 10−4). Figure 1 showed the
reconstruction of the time scaled Bayesian tree of the
17 D1 Moldavian sequences (third data set).
Comparing data from the Bayesian tree (Fig. 1) with
the date of arrival in Italy, we observed that whereas
only 3/17 (17.7 %) D1 Moldavian sequences were from
migrants arrived on the year 2003 most of the sequences
14/17 (82.3 %) were from migrants arrived in Italy from
2004 to 2008. In particular, 6/17 (35.2 %) migrants ar-
rived on 2004; 3/17 (17.7 %) on 2005; 4/17 (23.5 %) on
2006 and 1/17 (5.9 %) on 2008. The estimation of the
time of the tree’s root gave a mean value of 17 years ago
(95 % HPD between 24 and 10 years ago) this suggests
that the origin of the tree goes back 1992 year (C.I.
1985–1999), (Fig. 1).
Demographic history
The evolutionary demography of the Moldovan HBV D1
sequences (third dataset) was also investigated by
population dynamics analysis. BF analysis showed that
the BSP was favourite with respect to other models
(2 ln BF >11.6). The skyline plot (Fig. 2) showed that the
number of infections softly increased until the early
2005s, after which reached a plateau.
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Fig. 1 Bayesian phylogenetic tree of 17 Moldavian HBV S gene sequences. The time of the most recent common ancestor, with the credibility
interval based on 95 % highest posterior density interval (95 % HPD), was reported in years. Scale years is reported at the bottom of the figure
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HBV virus is widespread in the world. The different
route of transmission and the efficient dissemination
permitted its spreading in the world. Long-term persist-
ence, long incubation period and low frequency of symp-
toms helped HBV to maintain the high incidence rate in
many countries. In the present study, the genetic diver-
sity and demographic history of HBV in 43 HBV chron-
ically infected migrants, resident in north of Italy, by
using a Bayesian coalescent-based framework, was inves-
tigated. The most prevalent genotype in north-eastern
Europe, the Mediterranean basin, northern Africa, and
the Middle East is genotype D. It is highly prevalent in
the Indian sub-continent and a group of island in the
Indian Ocean with high endemic levels of HBV [20]; and
it has also been identified in Oceania [10].
Most migrants living in Italy come from areas
with intermediate or high prevalence of HBV infection
such as Eastern Europe (23.4 % of the total number
of documented migrants in Italy), Africa (22.1 %) and
Asia (18.8 %) and the first four ranking Countries are
Morocco, China, India and Albania [12].Palumbo et al. showed that 9.3 % - 10.7 % of individ-
uals recently migrated to Italy and hosted in temporary
camps in southern Italy tested HBsAg positive [21]. In a
recent study, HBsAg reactivity and associated risk fac-
tors among migrants who accessed the Service of Inter-
national Medicine of Brescia’s Local Health Authority
was assessed and the prevalent genotype was D [12].
The phylogenetic analysis of the 43 HBV S gene se-
quences obtained from migrants showed that the most
frequent genotype was sub-genotype D1 and that all iso-
lates with sub-genotypes D1, except one, were Moldovan
sequences. For this reason our analysis was focalized on
the 17 D1 Moldovan sequences. D1 is the most preva-
lent sub-genotype in East Europe, Balkans and north
Africa [22–24].
The time-scaled tree of the 17 D1 Moldavian se-
quences allowed to estimate the time to the most recent
common ancestor (TMRCA). The root of the tree was
dated back to the year 1992, thus suggesting that the
HBV D1 strains circulating in Moldovan migrants origi-
nated since that date. From the 1992 ancestor the 17 D1
Moldavian sequences clustered mainly together in a
Fig. 2 Bayesian skyline plot (BSP) of the 17 HIV Moldavian HBV S gene sequences. The effective number of infections is reported on the Y-axis.
Time is reported on the X-axis. The colored area corresponds to the credibility interval based on 95 % highest posterior density interval (HPD)
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(clade I) and consequently strains in this clade should be
circulating in this frame time.
Furthermore, the evolutionary demography of the
Moldovan HBV D1 sub genotypes sequences was
analyzed and an exponential growth of the number of
infections was observed between the early 2003 and
2005 whereas a plateau was reached in 2007 (Fig. 2).
Maximum Likelihood analysis and skyline plot showed
an intermixing mostly between Moldavian and for-
eigners as well as an exponential increasing number of
infections during 2003–2005.
The analysis of the 17 D1 sequences in the fourth data-
set, including the more prevalent D1 sequences from dif-
ferent countries, [23, 24] showed that the Moldavian
sequences were intermixed and mostly correlated with
Russian and other east European and Asiatic countries.
Interestingly, the major part of the Italian sequences
formed a clear separated clade than all other sequences.
Comparing these results to the date of arrival in
Italy, it should be possible to assume that infection of
migrants occurred in their country of origin. Thishypothesis was also supported by the skyline plot show-
ing that the number of infections softly increased until
the early 2005s.
Conclusions
In conclusion, this is the first paper where phylogenetic
analysis and genetic evolution are used to characterize
HBV sub-genotypes D1 circulation in a selected and
homogenous group of migrants coming from a restricted
area of East-Europe and to approximately define the
period of infection.
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Additional file 1: Figure S1. Likelihood mapping of the first (panel a),
second (panel b), third (panel c) and fourth (panel d) HBV S gene dataset. The
dots inside the triangles represent the likelihood of the possible unrooted
topologies for each quartet. Numbers indicate the percentage of dots in the
centre of the triangle corresponding to phylogenetic noise (star-like trees).
Villano et al. BMC Infectious Diseases  (2015) 15:287 Page 7 of 7Additional file 2: Figure S2. Maximum likelihood phylogenetic analysis
including 43 HBV S gene isolates sequences plus 105 genotype specific
reference sequences. The tree was rooted by the midpoint rooting. Branch
lengths were estimated with the best fitting nucleotide substitution model
according to a hierarchical likelihood ratio test, and were drawn to scale
with the bar at the bottom indicating 0.0060 nucleotide substitutions per
site. One asterisk (*) along the branches represents significant statistical
support for the clade subtending that branch (bootstrap value >70 %).
Additional file 3: Figure S3. Maximum likelihood phylogenetic tree of
the fourth dataset. The tree was rooted by the midpoint rooting. Branch
lengths were estimated with the best fitting nucleotide substitution model
according to a hierarchical likelihood ratio test, and were drawn to scale
with the bar at the bottom indicating 0.01 nucleotide substitutions per site.
One asterisk (*) along the branches represents significant statistical support
for the clade subtending that branch (bootstrap value > 70 %). The most
prevalent sequences are in color. Moldovan sequences were highlighted in
red, Italian sequences in blue, Russian in green, Iranian in violet, Turkey in
light blue and Lebanon in light green.
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